XC-302 free base T29165
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
XC-302 is a multi-targeted inhibitor, it induces autophagy of nasopharyngeal cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway.
CAS nr:
916890-10-3
Purity:
98%
Molecular Weight:
317,35
SMILES:
C1(NC2=NC(NC3CC3)=C(N=CN4)C4=N2)=CC=C5C(C=CC=N5)=C1
Formula:
C17H15N7
Pathway:
Target:
